New Sequencing System Maps Complex Immune Genes
The validated pipeline resolves difficult genomic regions, enabling scalable immune research across global populations.
Updated on Oct. 27, 2026 in Life Sciences
Researchers have validated an automated short-read sequencing system that achieves high-resolution genotyping of Killer Cell Immunoglobulin-like Receptor (KIR) genes. The system, which utilizes a multiplex PCR assay and the cloud-based Scisco pipeline, provides a new method for resolving complex human genetic haplotypes.
Why it matters
KIR genes play a critical role in immune response, but they have historically been difficult to sequence due to extreme structural diversity and high sequence similarity. This new method offers a scalable way to accurately map these complex regions, accelerating research into human immune function and disease susceptibility.
The system achieves 98.6% automated copy-number concordance and a 1.62% pipeline mismatch rate when benchmarked against phased PacBio long-read sequences. The study analyzed 2,298 individuals across 24 populations, processing 768 gene-sample comparisons to validate the method.
The players
Scisco
A cloud-based automated analysis pipeline designed for processing and identifying complex human genetic sequences.
The details
The system employs a four-reaction, two-stage multiplex PCR assay—a laboratory technique used to amplify multiple specific DNA targets simultaneously. This is combined with the Scisco cloud-based analysis pipeline, which is engineered to handle copy-aware allele detection by integrating short-read data. Researchers validated this approach by comparing results against phased PacBio sequences, a long-read sequencing technology that provides longer, more accurate DNA strands, reducing the errors typical in shorter-read platforms.
Timeline
October 27, 2026: The study detailing the sequencing system was published.
The Tech Race
This development addresses the long-standing challenge of mapping highly homologous gene regions that were previously only resolvable through expensive, lower-throughput long-read methods. By matching long-read benchmarks at population scale, the system shifts the trajectory for clinical immunogenetics.
This sequencing system is currently a research-stage tool, meaning its immediate impact is in the design of future large-scale genomic studies rather than clinical diagnostics. Researchers in immunology and genetics can now adopt this validated pipeline to standardize data across diverse global populations.
The takeaway
This method establishes a new accuracy benchmark for population-scale immune system mapping. Researchers should monitor future clinical trial papers to see how this system improves the characterization of patients with KIR3DL1/HLA-B Bw4 and KIR2DS4 receptor variations.
Further reading
For broader trends in mapping complex human DNA, visit the Life Sciences section.
Source note: This article includes information reported by Biorxiv.
